Skip to Content

Disclaimer

Disclaimer
MDS makes every effort to publish accurate information on the website. "Google Translate" is provided as a free tool for visitors to read content in one's native language. Translations are not guaranteed to be 100% accurate. Neither MDS nor its employees assume liability for erroneous translations of website content.

 

International Congress of Parkinson’s Disease and Movement Disorders ®

Congress
Main Content

Parallel Session 2404

Dystonia: From Mechanistic Models to New Therapeutic Avenues

Monday, October 6, 2025
14:00 - 15:30 | Room TBD

In this session, the faculty will present preclinical models and how this knowledge can be translated into advanced neuromodulation therapies in dystonia.


Chairs:

Florence Chang, Australia
William Dauer, USA

Presenters:

How are Animal Models Advancing Therapeutics in Dystonia?
David Standaert, USA

How are Patient Derived Cellular Models Advancing Therapeutics in Dystonia?
Kathryn Peall, United Kingdom

Targeting the Network Dysfunction of Dystonia: Therapeutic Advances
Daniel Corp

CSPC Liaisons:

Davide Martino, Canada

Learning Objectives

At the conclusion of this session, participants should be better able to:

  1. Discuss the validity of the existing animal models of dystonia and identify the pathophysiological mechanisms explored in these models
  2. Decide how patient-derived cellular models provide insights on the pathophysiology of dystonia and on future therapeutic approaches
  3. Discuss novel therapeutic advances in neuromodulation for dystonia

Recommended Audience

Clinician / General Neurology
Fellow / Resident / Student
Industry
Researcher / Basic Science

Education Level

Advanced / Expert
Intermediate / Experienced

Focus

Translational